Market Capitalization (Millions $) |
3 |
Shares
Outstanding (Millions) |
26 |
Employees |
34 |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-91 |
Cash Flow (TTM) (Millions $) |
-54 |
Capital Exp. (TTM) (Millions $) |
18 |
Oncorus Inc
Oncorus Inc is a biotechnology company dedicated to the development of innovative immunotherapies for the treatment of various types of cancers. The company focuses on developing viral-based therapies that can selectively infect and destroy cancer cells while leaving healthy cells intact. Oncorus uses a proprietary therapeutic platform called Synthetic Virus, which enables the design and production of potent viral vectors for therapeutic purposes. These viral vectors can deliver therapeutic payloads directly to cancer cells, enhancing the immune response and potentially improving patient outcomes. The company's mission is to improve the lives of cancer patients and advance the field of immuno-oncology through their innovative approaches.
Company Address: 4 Corporate Drive Andover 1810 MA
Company Phone Number: 320-6400 Stock Exchange / Ticker: NASDAQ ONCR
|